Navigation Links
Bioniche Hosts Veterinarians and Food Industry Reps at Two-Day E. coli O157:H7 Vaccine Conference
Date:6/27/2008

es at the University of Nebraska-Lincoln summarized the results of field studies with the Bioniche vaccine at university feedlots over the last six years. He noted that the Bioniche vaccine fulfils the expectations of an efficacious vaccine.

Another guest speaker was Dr. Guy Loneragan, Associate Professor, Agriculture Sciences and Epidemiologist in the Feedlot Research Group at West Texas A&M University. Dr. Loneragan discussed his analysis of the applied interventions against E. coli O157:H7 in real-world studies, as well as peer-reviewed publications. In response to the question, "How much intervention is enough?", Dr. Loneragan said, "If we knew the pathogen threshold level in meat processing plants - the acceptable level that meat processing and packing facilities can handle with internal interventions - we could easily assess the efficacy required of a pre-harvest intervention. Unfortunately, this threshold is yet to be well-defined. That said, however, the vaccine intervention appears to change summertime shedding patterns into winter-type patterns. Empirical data from human health tells us this change is important. I believe that vaccine technology probably has the broadest application and is the most widely implementable."

Dr. Doug Powell, Associate Professor in the Department of Diagnostic Medicine/Pathobiology at Kansas State University, discussed the need to create a food safety culture, from farm-to-fork, 24/7. He emphasized that risk reduction strategies are key to ensuring food safety. "The Bioniche vaccine is a technology to reduce risk. Any tool you can provide for risk reduction will help."

"We are pleased with the level of interest in our vaccine on the part of veterinarians, researchers and the food industry," said Rick Culbert, President of Bioniche Food Safety. "We are in an awareness building phase, whereby we are introducing various segments of the food industry to both our vaccine and the impact of E. coli O157:H7 on huma
'/>"/>

SOURCE Bioniche Life Sciences Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Bioniche Secures Final Financing to Scale-up E. coli O157:H7 Vaccine Production
2. Bioniche Presents E. coli O157:H7 Vaccine Data to International Congress of Medical Microbiology in Serbia
3. Bioniche Presents Pre-Clinical Research at Two International Conferences
4. Bioniche Updates re: Mycobacterial Cell Wall Technology Platform
5. Bioniche Reports Fiscal 2008 Third Quarter
6. Bioniche Appoints U.S. President of Food Safety
7. Bioniche Reports the Passing of its Board Chair
8. Bioniche Converts a Portion of its Debt to Equity
9. Bioniche Receives Fast Track Designation For First-Line Bladder Cancer Therapy
10. Bioniche Pharma Chooses TrackWise for its Deviation Control Solution
11. Bioniche Provides Update on Refractory Bladder Cancer Trial with Urocidin(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... 2014 Cooking and warming equipment ... of 5. This score reflects slightly positive negotiation conditions ... specialization, low switching costs and a low level of ... low availability of substitutes for cooking and warming equipment ... and aluminum, key inputs in the production process of ...
(Date:12/26/2014)... (PRWEB) December 26, 2014 “Many people ... with personal injury claim issues and phone calls with ... released an article featuring their free eBook on ... helpful eBook on pedestrian and bicycle auto accident claims ... is fully capable of professionally handling their case while ...
(Date:12/26/2014)... AZ (PRWEB) December 26, 2014 ... source for the best in heating, cooling and ... for 24 hour emergency services in 2014 with ... alike know that Arizona is known for its ... company that understands the intricacies and details of ...
(Date:12/25/2014)... 26, 2014 The report “Nintedanib ... 2023” focuses on the current treatment landscape, unmet ... colorectal cancer market. Stivarga is a drug which ... rectal cancer. Boehringer Ingelheim is developing nintedanib (BIBF-1120), ... of refractory CRC in the US, Europe, and ...
(Date:12/25/2014)... Recently, iFitDress.com, the popular online supplier of ... its new selection of black one-shoulder cocktail dresses . ... they are available at discounted prices, up to 70% off. ... last for three weeks only. You know, we have thousands ... interested in our new items can visit our website for ...
Breaking Medicine News(10 mins):Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Guide to Handling Pedestrian and Bicycle Accidents Released By The Jones Firm, Featured in Recent Article 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2
... , ... it,s time to shake off winter doldrums, lace up the running shoes and get moving. While ... System,s Geriatric Research, Education, and Clinical Center (GRECC) say that keeping active all year is the ... ...
... ... fertility in women and men, as well as infertility diagnosis, treatment and options. , ... (PRWEB) March 9, 2010 -- A ... are surprised when their attempts at conceiving aren,t successful within the first few months. , ...
... ... ... ... ...
... ... ... ... ...
... performing a hysterectomy is common practice to prevent the ... performed in 55 percent of all US women having ... article in the March/April issue of t Philadelphia, PA, ... oophorectomy) while performing a hysterectomy is common practice to ...
... , ... special pricing on cognitive skills testing in March, , ... Denver, CO (Vocus) March 9, 2010 -- Do you know the ... Month) and the local LearningRx cognitive skills’ experts are offering free tips, activities, ...
Cached Medicine News:Health News:The VA Maryland Health Care System Offers Tips for Senior Citizens and Older Adults to Spring into Shape 2Health News:The VA Maryland Health Care System Offers Tips for Senior Citizens and Older Adults to Spring into Shape 3Health News:The VA Maryland Health Care System Offers Tips for Senior Citizens and Older Adults to Spring into Shape 4Health News:The VA Maryland Health Care System Offers Tips for Senior Citizens and Older Adults to Spring into Shape 5Health News:'Get Pregnant' Aims To Help Couples Conceive Naturally, Faster 2Health News:2010 Recipient of Minority Scholar Award Will Conduct Clinical Research on Leukemia 2Health News:2010 Recipient of Minority Scholar Award Will Conduct Clinical Research on Leukemia 3Health News:2010 Recipient of Minority Scholar Award Will Conduct Clinical Research on Leukemia 4Health News:2010 Recipient of Minority Scholar Award Will Conduct Clinical Research on Leukemia 5Health News:U.S. Senator Kit Bond Receives 2010 AOA Health Care Leadership Award 2Health News:U.S. Senator Kit Bond Receives 2010 AOA Health Care Leadership Award 3Health News:U.S. Senator Kit Bond Receives 2010 AOA Health Care Leadership Award 4Health News:U.S. Senator Kit Bond Receives 2010 AOA Health Care Leadership Award 5Health News:New study questions benefits of elective removal of ovaries during hysterectomy 2Health News:Free Brain IQ Quiz, Activities for Home “Brain-Boosting” and Seminar Offered from LearningRX Denver during National Brain Awareness Month 2Health News:Free Brain IQ Quiz, Activities for Home “Brain-Boosting” and Seminar Offered from LearningRX Denver during National Brain Awareness Month 3Health News:Free Brain IQ Quiz, Activities for Home “Brain-Boosting” and Seminar Offered from LearningRX Denver during National Brain Awareness Month 4
(Date:12/24/2014)... -- ResMed (NYSE: RMD ) today announced its ... device manufacturer BMC Medical Co., Ltd. The ... below infringe ResMed,s patents, and entered an order prohibiting BMC ... the United States : , iVolve nasal ... nasal pillows mask , iVolve full face mask ...
(Date:12/24/2014)... , Dec. 23, 2014   Assurex Health, ... support to healthcare providers for behavioral health and ... secured $30 million in equity financing from new ... Drosos , President and Chief Executive Officer. ... and development of Assurex Health,s GeneSight ® ...
(Date:12/24/2014)... China , Dec. 23, 2014 ... pharmaceutical company that specializes in patented biopharmaceutical, modernized ... pharmaceutical ingredients (API) today announced that the Company ... its Good Manufacturing Practice (GMP) certificate of TPI,s ... Drug Administration,s (CFDA). The public notice period is ...
Breaking Medicine Technology:ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3
... Q2 Revenue Up 46% to $4.83 Million; Net Income Up 59%... -- BEIJING, Aug. 16 /PRNewswire-Asia-FirstCall/ -- ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... { var s = ,; var first_result; // Results are keyed by longUrl, so we need to ...
... Jiangbo Pharmaceuticals Announces the Commercial Launch of Felodipine Sustained Release Tablets -- LAIYANG, China, Aug. ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // ...
Cached Medicine Technology:Dehaier Medical Systems Q2 Revenue Up 46% to $4.83 Million; Net Income Up 59% to 1.14 Million; EPS 0.27 2Dehaier Medical Systems Q2 Revenue Up 46% to $4.83 Million; Net Income Up 59% to 1.14 Million; EPS 0.27 3Dehaier Medical Systems Q2 Revenue Up 46% to $4.83 Million; Net Income Up 59% to 1.14 Million; EPS 0.27 4Dehaier Medical Systems Q2 Revenue Up 46% to $4.83 Million; Net Income Up 59% to 1.14 Million; EPS 0.27 5Dehaier Medical Systems Q2 Revenue Up 46% to $4.83 Million; Net Income Up 59% to 1.14 Million; EPS 0.27 6Dehaier Medical Systems Q2 Revenue Up 46% to $4.83 Million; Net Income Up 59% to 1.14 Million; EPS 0.27 7Dehaier Medical Systems Q2 Revenue Up 46% to $4.83 Million; Net Income Up 59% to 1.14 Million; EPS 0.27 8Dehaier Medical Systems Q2 Revenue Up 46% to $4.83 Million; Net Income Up 59% to 1.14 Million; EPS 0.27 9Dehaier Medical Systems Q2 Revenue Up 46% to $4.83 Million; Net Income Up 59% to 1.14 Million; EPS 0.27 10Dehaier Medical Systems Q2 Revenue Up 46% to $4.83 Million; Net Income Up 59% to 1.14 Million; EPS 0.27 11Dehaier Medical Systems Q2 Revenue Up 46% to $4.83 Million; Net Income Up 59% to 1.14 Million; EPS 0.27 12Jiangbo Pharmaceuticals Announces the Commercial Launch of Felodipine Sustained Release Tablets 2Jiangbo Pharmaceuticals Announces the Commercial Launch of Felodipine Sustained Release Tablets 3Jiangbo Pharmaceuticals Announces the Commercial Launch of Felodipine Sustained Release Tablets 4Jiangbo Pharmaceuticals Announces the Commercial Launch of Felodipine Sustained Release Tablets 5Jiangbo Pharmaceuticals Announces the Commercial Launch of Felodipine Sustained Release Tablets 6Jiangbo Pharmaceuticals Announces the Commercial Launch of Felodipine Sustained Release Tablets 7
... creation of a vascular access, a correctly ... the utmost importance in many vascular procedures. ... seeking a high-precision tunneling instrument. The unique ... twisting or kinking for more accurate graft ...
... GORE-TEX Stretch Vascular Grafts have ... demanding vascular procedures. Recognized for exceptional ... the endorsement of renowned surgeons worldwide. ... dilatation and the spread of infection, ...
... vascular surgery, and the accompanying need for ... of graft be developed. Grafts must not ... also available in varying sizes and configurations ... has long been the prosthetic of choice ...
... newest vascular graft offering from W. L. ... surgical products for more than two decades, ... compression problems that can lead to ... of the benefits of a ring graft ...
Medicine Products: